The Cancer Center at Nicklaus Children's is engaged in more than 100 clinical cancer research studies
, all of which are focused on finding new cures, treatments and diagnostic procedures for pediatric malignancies. No hospital in the region features such a wide array of clinical trials for childhood cancer research. As such, the Cancer Center offers its patients unparalleled hope, offering the latest drug treatments, medical devices, biotechnology and other technological innovations in the fight against pediatric cancer. The Cancer Center at Nicklaus Children's has been recognized as a full member of the prestigious Children’s Oncology Group (COG)
, a nationally funded group of pioneering physicians and institutions. To maintain this standing, full compliance with COG requirements is mandated. Compliance in this group involves not only participation in and adherence to multi-center research protocols, but also submission of accurate and timely data. The center has also been awarded a grant by the National Cancer Institute to advance childhood cancer research. In addition, members of the team share their knowledge through publication of clinical research study findings and presentations to national societies of physician scientists.
Significant progress has been made in the early development of new treatments and diagnosis through childhood cancer research in laboratories at Nicklaus Children's. Molecular and genetic diagnosis and classification of pediatric brain tumors is being developed by micro-array technology. This leading-edge approach is being used for diagnostic and prognostic evaluation of malignant solid tumors. Also underway is work focused on the roles of cell growth in the development of drug resistance in pediatric cancers. In an exciting new effort, Nicklaus Children's has made progress in evaluating alternative medicines that are used to treat cancer in other cultures.